Higher TMAO Levels Track With Higher Blood Pressure in Adults
A study of 500 adults links higher TMAO to higher blood pressure, with significant associations in men and adults 60 or older. Causation remains unproven.
Summary
Higher blood levels of trimethylamine-N-oxide, or TMAO, were associated with higher blood pressure in a study of 500 Chinese adults from 173 families. Participants averaged about 57 years old. Each additional micromole per liter of TMAO was linked to a 0.74 mmHg higher systolic pressure, the upper blood pressure number, and a 0.64 mmHg higher pulse pressure, the gap between the upper and lower numbers. Associations were statistically significant in men and adults aged 60 or older, but not in women or younger adults. This does not prove that the relationships differ between these groups. Blood sugar and blood fat markers showed no significant associations. The findings do not establish causation or justify TMAO testing or treatment changes. This summary is based on the abstract only.
Detailed Summary
High blood pressure threatens cardiovascular health as adults age. Researchers are investigating whether trimethylamine-N-oxide, or TMAO, could help explain differences in blood pressure. This study examined associations between blood TMAO levels and cardiovascular and metabolic markers in Chinese adults. Its findings suggest a potential connection, but do not establish that TMAO causes higher blood pressure.
The analysis used baseline data collected between 2013 and 2017 from the Beijing Fangshan Family Cohort. It included 500 adults from 173 families, averaging about 57 years old; 54.2% were men. Researchers measured serum TMAO using laboratory assay kits and applied statistical models suited to data from related participants.
Each additional micromole per liter of TMAO was associated with systolic blood pressure that was 0.74 mmHg higher and pulse pressure that was 0.64 mmHg higher. Systolic pressure is the upper blood pressure number; pulse pressure is the difference between the upper and lower numbers. Both associations were statistically significant.
In subgroup analyses, associations were statistically significant in men and adults aged 60 or older, but not in women or younger adults. Among older adults, each additional micromole per liter corresponded to 1.10 mmHg higher systolic pressure and 0.98 mmHg higher pulse pressure. However, these results do not establish genuine differences between sexes or age groups. Blood glucose and lipid markers showed no statistically significant associations.
These findings support further research into TMAO as a potential cardiovascular marker, not routine testing or treatment changes. The study did not test whether lowering TMAO reduces blood pressure or prevents heart disease. Because the analysis was observational and assessed baseline measurements, cause and effect remain uncertain. Other health or lifestyle factors could explain the relationships. This summary relies on the abstract only; adjustment details and subgroup interaction tests were unavailable. Continue prioritizing established blood pressure monitoring and management strategies.
Key Findings
- Each 1 μmol/L higher TMAO was associated with 0.74 mmHg higher systolic pressure, with a 95% confidence interval of 0.19–1.30.
- Each 1 μmol/L higher TMAO was associated with 0.64 mmHg higher pulse pressure, with a 95% confidence interval of 0.21–1.08.
- Associations were significant in men and adults 60 or older, but subgroup results do not establish differences between sexes or age groups.
- TMAO showed no statistically significant associations with blood glucose or lipid markers.
- These observational findings do not justify routine TMAO testing or interventions to lower it.
Methodology
This cross-sectional analysis used baseline data collected in 2013–2017 from 500 participants in 173 families in the Beijing Fangshan Family Cohort. Serum TMAO was measured using enzyme-linked immunosorbent assay kits, and associations were evaluated using linear mixed-effects models. The abstract does not specify the full adjustment set or report subgroup interaction tests.
Study Limitations
This summary is based on the abstract only, limiting assessment of assay performance, confounder adjustment, and other methodological details. Cross-sectional associations cannot establish causation, and results from one Chinese family cohort may not generalize to other populations. Significant findings in some subgroups but not others do not establish true subgroup differences without appropriate interaction testing.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: